Página 9 - Melhores TC (tomografia computadorizada) médicos em Turquia - TOP-366 médicos

Education and Specialization

• Bachelor’s Degree in Medicine (English) – Hacettepe University, 1997
• Master’s Degree – Department of Internal Medicine, Akdeniz University, 2004
• Ph.D. / Proficiency / Medical Specialization – Division of Gastroenterology, Akdeniz University, 2007

Experience

• Akdeniz University Faculty of Medicine 1998/2004
• Akdeniz University Faculty of Medicine  2004/2007
• Urfa Training and Research Hospital 2008/2009
• Akdeniz University Faculty of Medicine, Department of Internal Medicine, Division of Gastroenterology  2010/2011
• Akdeniz University Faculty of Medicine, Department of Internal Medicine, Division of Gastroenterology 2011/2013
• Akdeniz University Faculty of Medicine, Department of Internal Medicine, Division of Gastroenterology 2013/2017
• Medical Park Antalya Hospital, Gastroenterology Department and Organ Transplant Center

Education and Specialization

• 1989 - 1995 Ondokuz Mayıs University Faculty of Medicine
• Istanbul University, Istanbul Faculty of Medicine – Specialization
• 2006 - Associate Professorship, Başkent University Faculty of Medicine

Experience

• 1995 - 1996 - Assistant Doctor, Emergency Department, Ardahan State Hospital
• 1996 - 1997 - Atatürk University Faculty of Medicine
• 1997 - 2002 - Istanbul University, Istanbul Faculty of Medicine, Department of Cardiology
• 2002 - Istanbul University, Istanbul Faculty of Medicine, Department of Cardiology
• 2003 - 2007 - Başkent University Konya Research and Application Center
• 2007 - 2012 - Süleyman Demirel University Faculty of Medicine, Department of Cardiology
• 2012 - 2017 - Süleyman Demirel University Faculty of Medicine, Department of Cardiology
• 2013 - 2014 - Mayo Clinic Echocardiography Lab, Rochester, MN, USA
• 2017 - 2020 - ASV Yaşam Hospital
• 2020 - 2021 - Antalya Anadolu Hospital

Education and Specialization

• 1989 - 1995 Ondokuz Mayıs University Faculty of Medicine
• Istanbul University, Istanbul Faculty of Medicine – Specialization
• 2006 - Associate Professorship, Başkent University Faculty of Medicine

Experience

• 1995 - 1996 - Assistant Doctor, Emergency Department, Ardahan State Hospital
• 1996 - 1997 - Atatürk University Faculty of Medicine
• 1997 - 2002 - Istanbul University, Istanbul Faculty of Medicine, Department of Cardiology
• 2002 - Istanbul University, Istanbul Faculty of Medicine, Department of Cardiology
• 2003 - 2007 - Başkent University Konya Research and Application Center
• 2007 - 2012 - Süleyman Demirel University Faculty of Medicine, Department of Cardiology
• 2012 - 2017 - Süleyman Demirel University Faculty of Medicine, Department of Cardiology
• 2013 - 2014 - Mayo Clinic Echocardiography Lab, Rochester, MN, USA
• 2017 - 2020 - ASV Yaşam Hospital
• 2020 - 2021 - Antalya Anadolu Hospital

EDUCATION:

2000 - SSK Okmeydanı Training and Research Hospital, .

1996 - Istanbul University, Istanbul Faculty of Medicine

EXPERIENCE:

2019 - Istanbul Medipol University Pendik Hospital

2017 - 2019 - Private Adatıp Kurtköy Hospital

2005 - 2017 - Private Avicenna Umut Hospital

2003 - 2005 - SSK Yalova Regional Hospital

2002 - 2003 - Kayseri Military Hospital

Education and Specialization

• 1982 - 1987: Ege University Faculty of Medicine
• 1987 - 1993: İzmir Atatürk Training and Research Hospital – Specialization

Experience

• 1993 - 1996: İzmir Atatürk State Hospital – Specialist Doctor
• 1996 - 1998: İnönü University Faculty of Medicine – Assistant Professor
• 1998 - 2001: İnönü University Faculty of Medicine – Associate Professor
• 2001 - 2005: Başkent University Adana Practice and Research Hospital – Associate Professor
• 2006 - 2007: Başkent University Adana Practice and Research Hospital – Professor
• 2007 - 2013: Başkent University Istanbul Practice and Research Hospital – Professor
• 2013 - 2015: Hisar Intercontinental Hospital, Istanbul – Professor
• 2015 - Present: Acıbadem Bakırköy Hospital, Istanbul – Professor

Education and Specialization

• 2006: Kocaeli University Faculty of Medicine
• 2014: Akdeniz University Faculty of Medicine, Internal Medicine
• 2018: Akdeniz University Faculty of Medicine, Medical Oncology

Experience

• 2006 - 2008: Konya Derebucak District Hospital
• 2009 - 2015: Akdeniz University Hospital
• 2015: Antalya Kaş State Hospital
• 2015 - 2016: İnönü University Faculty of Medicine
• 2016 - 2021: Akdeniz University Hospital
• 2021 - 2023: Antalya Training and Research Hospital

Dr. Mehmet Tonge is a neurosurgeon with expertise in Stereotactic and Functional Neurosurgery. He specializes in MR Guided Focused Ultrasound, deep brain stimulation, Gamma Knife Radiosurgery, and surgery for movement disorders, pain, and spasticity.

Dr. Tonge has published 32 articles in international and national journals and written 12 book chapters. He has presented 92 oral and poster presentations and delivered 41 invited lectures. He completed a Deep Brain Stimulation Fellowship at Maastricht University and finished the 4-year EANS training cycle. Dr. Tonge is known for his research and clinical work in functional neurosurgery.

Prof. Dr. Yasef began his medical education at Istanbul University in 1973 and graduated from Istanbul University Cerrahpaşa Faculty of Medicine in 1979. He started his specialization in neurology at the same university in 1980 and became a neurologist in 1985. During his specialty training, he spent 6 months at Hacettepe University in the Neurology Department in Ankara.

After becoming a neurologist, he completed 3.5 years of obligatory government service, spending the first 1.5 years at the Iskenderun Navy Hospital and the next 2 years at Diyarbakır Social Security Hospital. He returned to Istanbul University in 1989.

Prof. Dr. Yasef worked abroad in the United States from 1990 - 1991, focusing on dementia and behavioral neurology.

In 1994, he became an Associate Professor and continued working at Istanbul University until 1999. Between 1999 - 2002, he worked at Florence Nightingale Hospital, and then at Kozyatağı Acıbadem Hospital from 2004 to 2013.

Since 2013, he has been a valuable part of the team at Florence Nightingale Hospital.

Specialties

• Dementia
• Epilepsy
• Headaches

Work Experience

• Military Service at Iskenderun Navy Hospital, 1985 - 1986
• State Service at Diyarbakır S.S.K. Hospital, 1986 - 1989
• Florence Nightingale Hospital, 1999 - 2002
• Kozyatağı Acıbadem Hospital, 2004 - 2013
• Florence Nightingale Hospital (Since 2013)

PROFESSIONAL EXPERIENCE

2013 – Prof. Pediatric Orthopedic Surgeon, Istanbul Florence Nightingale Hospital, Istanbul

2013 – Prof. Istanbul Bilim University Medical Faculty, Department of Orthopedics and Traumatology, Istanbul

2011 – Assoc.Prof. Pediatric Orthopedic Surgeon, Florence Nightingale Hospital, Istanbul

2010 - 2011 – Chief II. Orthopedics Clinic, Assoc.Prof. SB Goztepe Training and Research Hospital, Istanbul

2006 - 2009 – Vice-Chief II. Orthopedics Clinic, Assoc.Prof. SB Goztepe Training and Research Hospital, Istanbul

1992 - 2005 – Vice-Chief II. Orthopedics Clinic, SB Goztepe Training and Research Hospital, Istanbul

1984 - 1991 – Orthopedist, SB Rize Hospital, Rize

1983 - 1984 – Orthopedist, Medical Sub-Lieutenant Kayseri Airborne Brigade, Kayseri

2004 - 2008 – Coordinator, Pediatric Orthopedics-Orthopedic Trauma-Ilizarov Meetings, Istanbul Hospitals

2002 - 2004 – President, TOTBID Pediatric Orthopedics Branch

COURSES ATTENDED

1997 - 2014 – Trainer, Ilizarov Limb Lengthening Courses

2012 – International Pediatric Orthopedic Symposium, Orlando FL

2011 – Instructor, AO Pediatric Trauma Course, Izmir

1996 – Graf Hip Ultrasonography Course, Vienna

MEMBERSHIPS

Turkish Medical Association

Turkish Society of Orthopedics and Traumatology (TOTBID)

Turkish Orthopedics and Traumatology Society (TOTDER)

Turkish Educational Council of Orthopedics and Traumatology

TOTBID Pediatric Orthopedics Branch

Turkish ASAMI (Ilizarov Applications and Research Center) Founding Member

EPOS (European Pediatric Orthopedics Society)

AAOS (American Academy of Orthopedic Surgeons

AWARDS

1) 2008. Chondroprotective effect of salicylate and chloroquine in pyogenic septic arthritis. SSK Göztepe Training and

Research Hospital Scientific Journal Competition First Place Award.

2) 2007. Modified Salter osteotomy for the treatment of developmental dysplasia of the hip:Description of a new

technique that eliminated the use of pins for internal fixation. TOTBİD Pediatric Orthopedics Branch Journal

Competition First Place Award

3) 2007. Modified Salter osteotomy for the treatment of developmental dysplasia of the hip:Description of a new

technique that eliminated the use of pins for internal fixation. SSK Göztepe Training and Research Hospital Scientific

Journal Competition Second Place Award.

4) 2005. Incomplete triple pelvic osteotomy for the surgical treatment of dysplasia of the hip in adolescents and

adults. TOTBİD Pediatric Orthopedics Branch Journal Competition Second Place Award

5) 2005. Incomplete triple pelvic osteotomy for the surgical treatment of dysplasia of the hip in adolescents and

adults. SSK Göztepe Training and Research Hospital Scientific Journal Competition First Place Award

6) 2004. A new capsuloplasty technique in DDH treatment. SSK Göztepe Training and Research Hospital Scientific

Journal Competition First Place Award

PROFESSIONAL EXPERIENCE

2011-2012
Erzurum Koprukoyu State Hospital
Department: General Medicine

2012-2017
Istanbul University Cerrahpaşa Medical Faculty
Department: Internal Medicine

06/2017-10/2017
Istanbul Gaziosmanpasa Taksim Training and Research Hospital
Department: Internal Medicine

10/2017-11/2018
Istanbul University Istanbul Medical Faculty
Department: Allergy and Immunology Fellowship

2018/2022
Istanbul University Oncology Institute
Department: Medical Oncology Fellowship

2022-2023
Tekirdag City Hospital
Department: Medical Oncology Specialist

2023-present
Istanbul Medipol University Medipol Bahcelievler Private Hospital
Department: Medical Oncology Assoc. Prof.

EDUCATION

2005-2011
Medical Education
Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey

2012-2017
Internal Medicine
Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey

2017-2018
Allergy-Immunology Fellowship
Istanbul University Istanbul Medical Faculty
Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey

2018-2022
Medical Oncology Fellowship
Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey

2022
ESMO Board Certification in Medical Oncology
10th September 2022 in Paris, France.

2023
Medical Oncology Assoc. Prof.
Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey

INTERNATIONAL CLINICAL TRIALS:

1. Astefania - ROCHE

• Title: A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
• Role: Subinvestigator

2. PFİZER

• Title: A Study Of Lorlatinib Versus Crizotinib In First-Line Treatment Of Patients With ALK-Positive NSCLC
• Role: Subinvestigator

3. RECITE - AMGEN

• Title: Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer
• Role: Subinvestigator

4. NAVIGATE - BAYER

• Title: A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors
• Role: Subinvestigator

5. RUBY - Tesaro (PRA)

• Title: A Phase 3, Randomized, Double-blind, Multicenter Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial Cancer
• Role: Subinvestigator

6. ENGOT-ov43/GOG-3036 - MSD

• Title: Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK001/ENGOT-ov43/GOG-3036)
• Role: Subinvestigator

7. ASTRA ZENECA

• Title: To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.
• Role: Subinvestigator

8. ROSY-O - ASTRA ZENECA

• Title: Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib
• Role: Subinvestigator
•  

INTERNATIONAL PUBLICATIONS

I. Published journal articles indexed by SCI, SSCI, and AHCI

Weekly Paclitaxel in Classic Kaposi Sarcoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Ahmed, M. A., Karaman, S., & Aydiner, A.
• Journal: Medicine, 102(5)

Carboplatin Desensitization in Ovarian Carcinoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Yildiz, A., Ak, N., & Aydiner, A.
• Journal: Medicine, 101(45), e31726

High-Dose Chemotherapy for Ewing’s Sarcoma

• Authors: Paksoy, N., Ferhatoglu, F., Dogan, İ., Khanmammadov, N., Celik, A. I., Gulbas, Z., & Başaran, M.
• Journal: Medicine, 101(49), e32213

Multidrug Refractory TFE3(+) Renal Cell Carcinoma

• Authors: Paksoy, Nail, et al.
• Journal: Journal of Oncology Pharmacy Practice, 2022, 28.1: 215-221

Crizotinib Efficacy in NSCLC with MET Alterations

• Authors: Gürbüz, M., Kiliçkap, S., Bilici, A., Karadurmuş, N., Sezer, A., Şendur, M. A. N., ... & Demirkazik, A.
• Journal: Medicine, 101(50), e32368

Clinicopathological Features in ALK Mutant NSCLC

• Authors: Dogan, I., Gurbuz, M., Paksoy, N., Ferhatoglu, F., Vatansever, S., Saip, P., ... & Aydiner, A.
• Journal: Medicine, 101(34)

PSMA-Based Tumor Burden in Prostate Cancer

• Authors: HAS SIMSEK, Duygu, et al.
• Journal: Annals of Nuclear Medicine, 2021, 35.6: 680-690

Atezolizumab in Metastatic Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: European Urology Focus, 2021, 7.5: 1061-1066

Pulmonary Sarcomatoid Carcinoma

• Authors: FERHATOGLU, Ferhat, et al.
• Journal: Oncology Research and Treatment, 2021, 44.11: 590-601

Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: International Journal of Clinical Oncology, 2021, 26.8: 1506-1513

Atezolizumab with Chemotherapy in Small Cell Lung Cancer

• Authors: GÜRBÜZ, Mustafa, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 1-9

FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer

• Authors: AY, Seval, et al.
• Journal: Journal of Chemotherapy, 2022, 1-7

Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients

• Authors: CIL, Ibrahim, et al.
• Journal: Tumori Journal, 2022, 108.1: 19-25

Real-Life Efficacy of Osimertinib in Advanced NSCLC

• Authors: HIZAL, Mutlu, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 148.6: 1501-1508

ALK-Positive Cells Percentage and Alectinib Efficacy

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Atcı, M. M., Kahraman, S., Kılıçkap, S., ... & Şendur, M. A. N.
• Journal: Journal of Cancer Research and Clinical Oncology, 149(8), 4141-4148

Real-World Data on Alectinib in ALK-Positive NSCLC

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Kılıçkap, S., Atcı, M. M., Kahraman, S., ... & Şendur, M. A. N.
• Journal: Future Oncology, 18(23), 2573-2582

Prognostic Factors in Metastatic RCC with T790M Mutation

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Desensitization Protocol in Lenalidomide Hypersensitivity Reactions

• Authors: DEMIR, Semra, et al.
• Journal: Annals of Allergy, Asthma & Immunology, 2019, 123.4: 394-397

Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity

• Authors: ÖZDEMIR, Seçil Kepil, et al.
• Journal: Allergy, 2019, 74.6: 1187-1190

Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors

• Authors: Ünal, Ç., Azizy, A., Karabulut, S., Taştekin, D., Akyıldız, A., Yaşar, S., ... & Sağlam, S.
• Journal: The Oncologist, oyad257

Subsequent Treatments in Hormone-Positive Breast Cancer Progression

• Authors: Karacin, C., Oksuzoglu, B., Demirci, A., Keskinkılıç, M., Baytemür, N. K., Yılmaz, F., ... & Hacıbekiroğlu, İ.
• Journal: BMC cancer, 23(1), 192

Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Saip, P., & Aydiner, A.
• Journal: Scientific Reports, 13(1), 8779

Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Ferhatoğlu, F., Ak, N., ... & Aydiner, A.
• Journal: Journal of Cancer Research and Clinical Oncology, 1-9

Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer

• Authors: Doğan, İ., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydıner, A.
• Journal: European Journal of Breast Health, 19(2), 128

Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer

• Authors: Kahraman, S., Erul, E., Seyyar, M., Gumusay, O., Bayram, E., Demirel, B. C., ... & Nahit Sendur, M. A.
• Journal: Future Oncology, 19(10), 727-736

Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer

• Authors: Erol, C., Sakin, A., Basoglu, T., Ozden, E., Cabuk, D., Dogan, M., ... & Sendur, M. A. N.
• Journal: [Not specified]

Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma

• Authors: Khanmammadov, N., Paksoy, N., Doğan, I., Ferhatoğlu, F., Saip, P., & Aydiner, A.
• Journal: Medicine, 102(39), e35383

Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma

• Authors: Pehlivan, M., Paksoy, N., Aydin, E., Basaran, M., & Ekenel, M.
• Journal: Medicine, 102(41), e35245

Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)

Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)

Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.

Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49

Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4

Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.

Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY

Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology

Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)

Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)

Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)

Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)

Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye

Thesis:

Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)

International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)

Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination

• Authors: Dogan, I., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydiner, A. (2022)

Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study

• Authors: Şenocak Taşçi, E., Oyan, B., Sonmez, O., Mutlu, A. U., Atcı, M. M., Oner, I., ... & Gulmez, A. (2022)

Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer

• Authors: Dogan, I., Aydin, E., Paksoy, N., Ferhatoglu, F., Ak, N., Ibis, K., ... & Aydiner, A. (2021)

Efficacy of temozolomide in pretreated patients with metastatic sarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors

• Authors: Ferhatoglu, F., Paksoy, N., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases

• Authors: Dogan, İ., Iribas, A., Paksoy, N., Ekenel, M., Vatansever, S., & Basaran, M. (2021)

Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma

• Authors: Tural, D., Olmez, O. F., Sümbül, A. T., Artac, M., Ozhan, N., Akar, E., ... & Erman, M. (2021)

Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study

• Authors: Esin, E., Ahmed, M. A., Yıldırım, H. Ç., Mandel, N. M., Erdemoglu, E., Sari, M., ... & Paydas, S. (2023)

Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences

• Authors: Tural, D., Ölmez, Ö. F., Sümbül, A. T., Artaç, M., Özhan, N., Akar, E., ... & Kılıçkap, S. (2021)

Education:

Bachelor's Degree

• Field: Faculty of Medicine
• University: Gazi University
• Years: 2009-2015

PhD/Medical Specialty

• Field: Department of Internal Medicine/Cardiology Department
• University: Mustafa Kemal University
• Years: 2016-2020

Experience:

General Practitioner

• Institution: Kırıkhan Community Health Center
• Years: 2015-2016

Research Assistant Doctor

• Institution: Hatay Mustafa Kemal University Faculty of Medicine Cardiology Department
• Years: 2016-2020

Specialist Doctor

• Institution: Hatay Training and Research Hospital
• Years: 2020-2022

Doctor Academic Staff

• Institution: Hatay Mustafa Kemal University Faculty of Medicine Cardiology Department
• Years: 2022-2024
•  

Education & Expertise

1995 to 2001 | Ege University Faculty of Medicine – Medical Education

2001 to 2006 | Dokuz Eylül University Faculty of Medicine – Internal Medicine Specialization

2008 to 2011 | Göztepe Training and Research Hospital – Gastroenterology Subspecialty

2014 | Ümraniye Training and Research Hospital – Associate Professor of Gastroenterology

2021 | University of Health Sciences – Professor

Professional Experience

2007 | Nusaybin State Hospital – Internal Medicine Specialist (Civil Service Obligation)

2011 to 2014 | Ümraniye Training and Research Hospital – Gastroenterology Specialist

2014 to 2017 | Ümraniye Training and Research Hospital – Associate Professor of Gastroenterology

2017 to 2021 | Health Sciences University – Associate Professor of Gastroenterology

2015 to 2021 | Ümraniye Training and Research Hospital Gastroenterology Clinic – Clinic Chief

2021 to 2022 | University of Health Sciences – Professor of Internal Medicine and Gastroenterology

2015 to 2022 | Genomic Laboratory (GLAB) Coordinator, Istanbul Provincial Health Directorate

2014 to 2021 | Northern Clinics of Istanbul Journal (indexed in WoS and PubMed) – Founding Editor

2021 to Present | Turkish Liver Research Association – Board Member

2022 to Present | Hepatology Bulletin Journal – Editor

2019 to Present | Hepatology Forum Magazine – Editor

2016 to Present | World Journal of Hepatology – Editor

International Experience

1999 | Trainee Doctor, Regional Infectious Diseases Unit, Western General Hospital, Edinburgh, UK

2000 | Trainee Doctor, Cardiology Unit, North Manchester General Hospital, Manchester, UK

2005 | Assistant Doctor, Regional Infectious Diseases Unit, Western General Hospital, Edinburgh, UK

Professional Memberships

Turkish Gastroenterology Association

Turkish Liver Research Association

EASL – European Association for the Study of Liver

APASL – Asian Pacific Association for the Study of Liver

AAAS – American Association for the Advancement of Science

Awards & Recognitions

2013 | Liver Fibrosis Pathways in Chronic Hepatitis B: A Comparative Proteomic Study – Gilead Fellowship Award

2014 | Liver Fibrosis Pathways in Chronic Hepatitis B: A Comparative Proteomic Study – Viral Hepatitis Fight Association Project Support Award

2014 | The Relationship between Spontaneous Seroconversion and Toll-Like Receptor Gene Polymorphism in Hepatitis B Infection – Turkish Gastroenterology Association, Best Poster Second Prize

2015 | Research on Damage Pathways in Liver Tissue in Chronic Hepatitis B: A Comparative Proteomic Study – Turkish Gastroenterology Association, Best Oral Presentation Third Prize

2016 | Investigations of the EGF and Its Receptor EGFR Gene Variants in Ulcerative Colitis – XV Euroasian Congress of Gastroenterology and Surgery, Best Oral Presentation Third Prize

Dr. Seymur Aslanov is a specialist in internal medicine and gastroenterology. He received advanced training at Ege University Faculty of Medicine Hospital. Dr. Aslanov diagnoses and treats many gastrointestinal diseases. His expertise includes inflammatory bowel diseases, digestive system cancers, liver and pancreatic diseases, and gastrointestinal bleeding.

He is skilled in advanced endoscopic procedures. These include ERCP, colonoscopy, endoscopic polypectomy, and stenting for gastrointestinal stenosis. Dr. Aslanov has worked as a research assistant and subspecialist at Ege University. He has also served as an internal medicine specialist at Izmir Medical Point.

He is a member of the Izmir Medical Chamber.

Dr. Ercan Ozden is a specialist in internal medicine and medical oncology. He earned his medical degree and completed his residency at Istanbul University, Cerrahpaşa Faculty of Medicine. He later received a subspecialty in medical oncology at Kocaeli University Faculty of Medicine from 2016 to 2020.

Dr. Ozden has worked in medical oncology at Şırnak State Hospital. He has also served as an internal medicine specialist at Bağcılar Private Safa Hospital and Küçükçekmece Batı Bahat Hospital. He has extensive clinical experience in both internal medicine and oncology.

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Dr. Ali Osman Mucuoglu is a neurosurgeon. He completed his neurosurgery residency at Dokuz Eylül University from 2013 to 2019 after graduating from Eskişehir Osmangazi University in 2012 (2005–2012). He worked at Dokuz Eylül University and Muş State Hospital from 2019 to 2021. He has practiced at Atlas University Hospital since 2021.

He has five publications. These include a case report in the International Journal of Surgery Case Reports that has been cited seven times. He also reported on 3D printer‑assisted transsphenoidal hypophysectomy and on emergency minimally invasive intracerebral hemorrhage (ICH) surgery. He delivered an oral presentation at the 33rd Turkish Neurosurgical Society Congress in 2019.

He is a member of the Turkish Neurosurgical Society, the European Association of Neurosurgical Societies, and the Istanbul Chamber of Medicine. His advanced training includes spinal surgery courses in 2016 and 2017, the European Training Course on Head Injury and Functional Neurosurgery in 2017, and Surgical Neuroanatomy in 2017. He also holds an animal experimentation certificate from 2016.

Dr. Fırat Oruç is an Orthopedics and Traumatology specialist with 20 years of experience (since 2005). He has worked at Medical Park Antalya Hospital Complex since 2008. He previously worked at Private Lara Hospital (2005–2007) and completed his military service at GATA Istanbul (2007–2008).

Clinical focus includes knee, shoulder, and hip surgery; joint prostheses; soft tissue and bone tumors; pediatric orthopedics; and hand surgery. He earned his medical degree from Akdeniz University Faculty of Medicine (1993–1999). He completed his Orthopedics and Traumatology residency at Akdeniz University (1999–2005).

Prof. Dr. Mehmet Sait Buğdacı is a highly experienced physician specializing in Internal Medicine and Gastroenterology. He completed his medical education and specialty training at Istanbul University Cerrahpaşa Faculty of Medicine and Şişli Etfal Training and Research Hospital. His clinical interests include gastrointestinal diseases, endoscopic procedures, and clinical research. He has contributed to medical education through numerous scientific publications and textbooks and currently sees patients at Central Hospital.

Areas of Interest • Pediatric gastrointestinal surgery • Anorectal malformations and motility disorders • Minimally invasive pediatric surgery • Pediatric colorectal and pelvic floor disorders

Dr. Adil Turan is a specialist in Orthopedics and Traumatology. He completed medical school at Trakya University (1996–2003). He finished his residency at İzmir Bozyaka Training and Research Hospital (2004–2009). In 2020, he conducted trauma research at Denver Health Hospital in Denver, USA.

He worked at Kızıltepe State Hospital (2009–2010). He then served as an Orthopedic Specialist at Antalya Training and Research Hospital (2010–2013) and Ordu State Hospital (2013–2015). He was Chief Assistant at Antalya Training and Research Hospital (2016–2020). He was Associate Professor and Instructor at Antalya Training and Research Hospital (2020–2022) and at the Health Sciences University Antalya Health Application Center (2023).

His professional memberships include the Turkish Orthopedics and Traumatology Association, the Turkish Sports Injuries Arthroscopy and Knee Surgery Association, the Turkish Orthopedics and Traumatology Education Council (since 2016), and the Turkish Medical Association.